Hydroxychloroquine retinopathy. (2017)
Attributed to:
Development of AAV gene therapy for blindness caused by cone-rod dystrophy
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/eye.2016.298
PubMed Identifier: 28282061
Publication URI: http://europepmc.org/abstract/MED/28282061
Type: Journal Article/Review
Volume: 31
Parent Publication: Eye (London, England)
Issue: 6
ISSN: 0950-222X